贵州地区肺动脉高压现状分析(4)
[10] Humbert M， Sitbon O，Chaouat A，et al.Pulmonar y arterial hypertension in France：results from a national registry[J].Am J Respir Crit Care Med，2006，173(9)：1023-1030.
[11] Walker AM，Langleben D， Korelitz JJ，et al.Temporal trends and drug exposures in pulmonary hypertension：an American experience[ J].Am Heart J，2006，152(3)：521-526.
[12] Badesch DB，Raskob GE，Elliott CG，et al.Pulmonary arterial hypertension：baseline characteristics from the REVEAL Registry[J].Chest，2010，137(2)：376-387.
[13] Wysowski DK， Golden L， Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States，1982-1992[J].ObstetGynecol，1995，85(1)：6-10.
[14] Bret KM，Madans JH.Use of postmenopausal hormone replacement therapy：estimates from a nationally representative cohort study[J].Am J Epidemiol，1997，145(6)：536-545.
[15] Farber HW，Foreman AJ，Miller DP，et al.REVEAL Registry：correlation of right heart catheterization and echocardiography in patients with pulmonary arterial hypertension[J].Congest Heart Fail，2011，17(2)：56-64., 百拇医药(司晓云 李伟 潘家义 石林艳 胡欢 王龙 段小容)
[11] Walker AM，Langleben D， Korelitz JJ，et al.Temporal trends and drug exposures in pulmonary hypertension：an American experience[ J].Am Heart J，2006，152(3)：521-526.
[12] Badesch DB，Raskob GE，Elliott CG，et al.Pulmonary arterial hypertension：baseline characteristics from the REVEAL Registry[J].Chest，2010，137(2)：376-387.
[13] Wysowski DK， Golden L， Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States，1982-1992[J].ObstetGynecol，1995，85(1)：6-10.
[14] Bret KM，Madans JH.Use of postmenopausal hormone replacement therapy：estimates from a nationally representative cohort study[J].Am J Epidemiol，1997，145(6)：536-545.
[15] Farber HW，Foreman AJ，Miller DP，et al.REVEAL Registry：correlation of right heart catheterization and echocardiography in patients with pulmonary arterial hypertension[J].Congest Heart Fail，2011，17(2)：56-64., 百拇医药(司晓云 李伟 潘家义 石林艳 胡欢 王龙 段小容)